Funck, Jr. Robert E. 4
4 · ABBOTT LABORATORIES · Filed Mar 2, 2023
Insider Transaction Report
Form 4
Funck Robert E
Vice President, Controller
Transactions
- Sale
Common shares without par value
2023-03-01$100.70/sh−1,264$127,285→ 218,237 total - Tax Payment
Common shares without par value
2023-02-28$99.77/sh−11,500$1,147,355→ 219,501 total
Holdings
- 10,000(indirect: By Trust)
Common shares without par value
- 500(indirect: By Daughter)
Common shares without par value
- 10,000(indirect: By Trust)
Common shares without par value
- 18,405(indirect: By Trust)
Common shares without par value
Footnotes (3)
- [F1]Held in daughter's annual gift trust. The reporting person disclaims beneficial ownership of all securities held by the trust.
- [F2]Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2023.
- [F3]The reporting person disclaims beneficial ownership of all securities held by his daughter.